Copyright
©2012 Baishideng Publishing Group Co.
World J Cardiol. Feb 26, 2012; 4(2): 36-47
Published online Feb 26, 2012. doi: 10.4330/wjc.v4.i2.36
Published online Feb 26, 2012. doi: 10.4330/wjc.v4.i2.36
Author study/date | Design | Study population | Patients | Age (mean, yr) | P | Complications < admission (%) | P | ||||
Men | Women | Men | Women | Men | Women | ||||||
Lansky et al[22] 2005 | RCT | AMI + PTCA | 1520 | 562 | 57.0 | 66.0 | < 0.001 | MACE | 3.2 | 6.4 | 0.002 |
Bleeding | 2.0 | 5.2 | 0.0003 | ||||||||
Lansky et al[67] 2009 | RCT | PCI | 687 | 314 | 61.8 | 65.9 | < 0.0001 | MACE1 | 1.3 | 3.2 | 0.0766 |
Vascular1 | 0.6 | 1.0 | 0.6844 | ||||||||
MI1 | 1.0 | 2.9 | 0.0526 | ||||||||
Tizón-Marcos et al[33] 2009 | RCT | PCI | 1050 | 298 | 59.7 | 62.5 | < 0.0001 | MACE1 | 3.9 | 3.4 | 0.86 |
Bleeding1 | 1.1 | 2.4 | 0.16 | ||||||||
MI1 | 3.5 | 3.0 | 0.86 | ||||||||
Thompson et al[53] 2006 | Pros cohort | PCI | 807 | 359 | 61.7 | 67.7 | < 0.0001 | MACE | 2.7 | 3.9 | 0.29 |
Vascular | 4.2 | 12.0 | < 0.0001 | ||||||||
Jibran et al[81] 2010 | Retro cohort | ACS + PCI | 331 | 137 | 60.7 | 66.1 | < 0.0001 | MACE1 | 3.9 | 2.9 | 0.8 |
Access site1 | 1.5 | 6.2 | 0.02 | ||||||||
MI1 | 1.5 | 0.7 | 1.0 | ||||||||
Duvernoy et al[43] 2010 | Pros cohort | PCI | 14 848 | 7877 | 61.9 | 66.9 | < 0.001 | MACE | 4.48 | 5.19 | < 0.001 |
Vascular | 1.02 | 3.34 | < 0.001 | ||||||||
MI | 1.60 | 1.66 | 0.70 | ||||||||
Bufe et al[62] 2010 | Pros cohort | STEMI + PCI | 376 | 124 | 58 | 65 | < 0.001 | Shock | 10.1 | 11.3 | 0.838 |
Renal failure | 1.3 | 1.6 | 0.835 | ||||||||
Reynolds et al[30] 2007 | RTC | MI | 12 498 | 4090 | 59.5 | 67.0 | < 0.001 | CVA1 | 0.2 | 0.6 | < 0.01 |
Heart failure | 4.0 | 6.7 | < 0.001 | ||||||||
Re-MI | 2.7 | 3.5 | 0.004 | ||||||||
Matsui et al[26] 2002 | Retro cohort | AMI | 346 | 136 | 62.9 | 70.4 | Heart failure | 16 | 26 | 0.013 | |
Re-MI | 5 | 6 | 0.568 | ||||||||
Moriel et al[28] 2005 | Pros cohort | ACS | 820 | 511 | 78 | 79 | 0.12 | CVA | 2 | 1 | 0.79 |
Heart failure | 21 | 21 | 0.86 | ||||||||
Re-MI | 15 | 14 | 0.61 | ||||||||
Uva et al[35] 2009 | RCT | CABG | 1485 | 481 | 64.7 | 69.0 | 0.001 | MACE | 3.9 | 6.6 | NS |
CVA | 0.7 | 1.2 | 0.2 | ||||||||
MI | 0.7 | 1.3 | 0.08 | ||||||||
Herlitz et al[18] 2009 | Retro cohort | AMI | 835 | 588 | 72.7 | 79.2 | < 0.0001 | Re-MI | 4 | 2 | 0.02 |
Toumpoulis et al[34] 2006 | Pros cohort | CABG | 2598 | 1162 | 63.2 | 66.2 | < 0.001 | CVA | 2.8 | 4.2 | NS |
Bleeding | 1.8 | 1.5 | 0.592 | ||||||||
MI | 0.6 | 0.7 | 0.657 | ||||||||
Liu et al[25] 2008 | Pros cohort | STEMI + PCI | 143 | 116 | 68.1 | 68.7 | 0.61 | MACE | 4.2 | 6.0 | 0.50 |
Berger et al[10] 2006 | Pros cohort | PCI | 2953 | 1331 | 61.9 | 66.8 | < 0.001 | MACE | 2.9 | 3.0 | 0.922 |
CVA | 0.1 | 0.2 | 0.905 | ||||||||
MI | 1.6 | 1.7 | NS | ||||||||
Access site | 0.0 | 0.3 | 0.018 | ||||||||
Chiu et al[13] 2004 | Pros cohort | PCI | 12 738 | 5301 | 62.3 | 66.5 | < 0.001 | Transfusion | 4 | 12 | < 0.001 |
Haematoma | 5 | 6 | 0.568 | ||||||||
Setoguchi et al[31] 2008 | Pros cohort | AMI | 317 | 1308 | 80 | 82 | < 0.001 | CVA | 3 | 4 | 0.57 |
Singh et al[79] 2008 | Retro cohort | PCI | 7616 | 3365 | 64.7 | 69.4 | 0.48 | CVA | 0.5 | 0.9 | 0.29 |
MI | 1.1 | 1.4 | 0.44 | ||||||||
Tillmanns et al[32] 2005 | Pros cohort | STEMI | 513 | 178 | 60 | 66 | < 0.0001 | Re-MI | 3 | 2 | NS |
- Citation: Claassen M, Sybrandy KC, Appelman YE, Asselbergs FW. Gender gap in acute coronary heart disease: Myth or reality? World J Cardiol 2012; 4(2): 36-47
- URL: https://www.wjgnet.com/1949-8462/full/v4/i2/36.htm
- DOI: https://dx.doi.org/10.4330/wjc.v4.i2.36